OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
November 22, 2022
The $286 million investment ability is designed to elevate MillioporeSigma’s ability to conduct biosafety testing and analytical development services.
November 21, 2022
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
November 11, 2022
The new Massachusetts facility will strengthen Cytiva’s cell culture services.
October 26, 2022
Cambrex has expanded its stability storage business, Q1 Scientific, in Ireland and Belgium.
September 19, 2022
Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility.
September 02, 2022
By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.
August 22, 2022
Grand River Aseptic Manufacturing has completed phase II of its facility expansion with the installation of two new sterile filling lines.
August 03, 2022
This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
July 19, 2022
TFF Pharmaceuticals is expanding its R&D operations with a new facility in Austin, Texas.
July 12, 2022
Wacker is investing more than €100 million (US$100.5 million) to expand its Halle, Germany, site with an mRNA competence center.